CLINICAL_TRIALS
ClinicalTrials.gov record update
Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis: A Phase IV Multicenter Interventional Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07059130
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:36.710072+00:00
- Published At
- 2025-07-10T00:00:00+00:00
- Record Updated At
- 2025-07-10
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Crohn Disease (CD)", "Crohns Disease", "Ulcerative Colitis (UC)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-10"- protocolSection.identificationModule.nctId
"NCT07059130"- protocolSection.identificationModule.officialTitle
"Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn\u0027s Disease and Ulcerative Colitis: A Phase IV Multicenter Interventional Study"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.